Medical Economics October 29, 2024
Grace Halsey

Key Takeaways

  • Over 75% of family and internal medicine physicians have prescribed GLP-1 receptor agonists for weight loss.
  • The survey examined physicians’ experiences with GLP-1RAs, focusing on effectiveness, side effects, and cost.
  • Physicians and patients consider both the benefits and potential drawbacks, including side effects and financial implications.

Doctors offer insights on the how they and their patients are using GLP-1RA medicines.

If it feels like the new antiobesity medicines are everywhere, you may not far off.

More than three-quarters of family medicine...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, Patient / Consumer, Pharma / Biotech, Primary care, Provider, Survey / Study, Trends
Related Articles:
10 recent Amazon healthcare moves
Premise Health scores big with data ingestion and analytics technologies
Which health systems are partnering with Amazon, Google, Microsoft
ACP joins call to keep health insurance tax credits for ACA Marketplace plans
HLTH 2024: Key takeaways from the 2024 HLTH conference

Share This Article